🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/09/2022 | 0,6900 USD |
| 14/06/2022 | 0,6900 USD |
| 14/03/2022 | 0,6900 USD |
| 14/12/2021 | 0,6900 USD |
| 14/09/2021 | 0,6500 USD |
| 14/06/2021 | 0,6500 USD |
| 12/03/2021 | 0,6202 USD |
| 14/12/2020 | 0,6202 USD |
| 14/09/2020 | 0,5821 USD |
| 12/06/2020 | 0,5821 USD |
| 13/03/2020 | 0,5821 USD |
| 13/12/2019 | 0,5821 USD |
| 13/09/2019 | 0,5248 USD |
| 14/06/2019 | 0,5248 USD |
| 14/03/2019 | 0,5248 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/08/1982 | 1,84 | 1,88 | 1,80 | 1,83 | +1,66% | 4,34% | 11.793.773 |
| 17/08/1982 | 1,77 | 1,80 | 1,74 | 1,80 | +3,63% | 3,75% | 7.013.635 |
| 16/08/1982 | 1,73 | 1,74 | 1,72 | 1,74 | +1,94% | 1,53% | 4.455.677 |
| 13/08/1982 | 1,71 | 1,72 | 1,70 | 1,70 | -0,77% | 1,35% | 6.070.435 |
| 12/08/1982 | 1,73 | 1,75 | 1,72 | 1,72 | -1,52% | 1,92% | 12.091.824 |
| 11/08/1982 | 1,75 | 1,76 | 1,73 | 1,74 | -0,94% | 1,90% | 3.357.792 |
| 10/08/1982 | 1,76 | 1,78 | 1,74 | 1,76 | +1,53% | 1,89% | 4.832.957 |
| 09/08/1982 | 1,74 | 1,75 | 1,72 | 1,73 | -0,95% | 1,53% | 7.839.878 |
| 06/08/1982 | 1,76 | 1,77 | 1,75 | 1,75 | -0,56% | 1,51% | 3.387.974 |
| 05/08/1982 | 1,77 | 1,80 | 1,74 | 1,76 | -2,21% | 3,37% | 5.983.661 |
| 04/08/1982 | 1,81 | 1,83 | 1,80 | 1,80 | -3,03% | 1,83% | 4.217.990 |
| 03/08/1982 | 1,88 | 1,90 | 1,86 | 1,86 | -1,75% | 2,29% | 5.881.795 |
| 02/08/1982 | 1,87 | 1,89 | 1,86 | 1,89 | +1,97% | 1,77% | 2.776.781 |
| 30/07/1982 | 1,86 | 1,87 | 1,84 | 1,85 | +0,36% | 1,61% | 3.142.742 |
| 29/07/1982 | 1,83 | 1,85 | 1,81 | 1,85 | +1,08% | 1,99% | 5.787.475 |
| 28/07/1982 | 1,83 | 1,84 | 1,82 | 1,83 | -0,18% | 0,91% | 3.369.110 |
| 27/07/1982 | 1,84 | 1,84 | 1,83 | 1,83 | +0,00% | 0,90% | 3.210.653 |
| 26/07/1982 | 1,84 | 1,85 | 1,82 | 1,83 | -1,78% | 1,62% | 2.942.784 |
| 23/07/1982 | 1,87 | 1,88 | 1,86 | 1,86 | +0,36% | 1,24% | 4.946.141 |
| 22/07/1982 | 1,85 | 1,87 | 1,83 | 1,86 | +0,72% | 1,79% | 5.621.472 |
| 21/07/1982 | 1,87 | 1,90 | 1,84 | 1,84 | -2,11% | 2,84% | 9.047.174 |
| 20/07/1982 | 1,85 | 1,88 | 1,81 | 1,88 | +4,60% | 3,95% | 9.137.722 |
| 19/07/1982 | 1,81 | 1,82 | 1,79 | 1,80 | +0,74% | 1,65% | 5.459.242 |
| 16/07/1982 | 1,78 | 1,80 | 1,77 | 1,79 | +0,56% | 1,49% | 8.337.888 |
| 15/07/1982 | 1,79 | 1,80 | 1,78 | 1,78 | +0,00% | 1,11% | 4.138.762 |
| 14/07/1982 | 1,77 | 1,78 | 1,76 | 1,78 | +0,19% | 1,12% | 4.617.907 |
| 13/07/1982 | 1,78 | 1,80 | 1,77 | 1,77 | -0,19% | 1,49% | 3.489.840 |
| 12/07/1982 | 1,77 | 1,78 | 1,76 | 1,78 | -0,55% | 1,12% | 4.617.907 |
| 09/07/1982 | 1,79 | 1,81 | 1,77 | 1,79 | +0,00% | 2,23% | 6.745.766 |
| 08/07/1982 | 1,75 | 1,79 | 1,72 | 1,79 | +3,26% | 3,97% | 8.605.757 |